Brought to you by:
Terumo Aortic announces ‘significant policy milestone’ with CMS establishing new DRG 209 for complex aortic arch procedures
Terumo Aortic today announced what it describes as a “significant policy milestone” with the Centers for Medicare & Medicaid Services (CMS) establishing a new Medicare Severity Diagnosis-Related Group (MS-DRG), MS-DRG 209, for complex aortic arch procedures. A company press release…
Appeal filed over ‘not-approvable’ letter for breakthrough venous valve replacement
Venous valve developer enVVeno Medical has announced that it will file a request for supervisory appeal of the “not-approvable” letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) received on Aug. 19,…
Updated intermittent claudication guidelines reflect a decade of new evidence
The Society for Vascular Surgery (SVS) recently published comprehensive update to its clinical practice guidelines (CPGs) for the management of intermittent claudication (IC), urging clinicians to prioritize conservative treatment strategies and patient-centered care. The new recommendations, which appeared in the…
SVS Highway to Health campaign aims to make PAD a household term
The Society for Vascular Surgery (SVS) is ramping up its national Highway to Health campaign to educate the public about peripheral arterial disease (PAD) and the importance of early detection as part of September’s PAD Awareness Month. Anahita Dua, MD,…
Gregorio A. Sicard, past SVS president, advocate for Latin American surgeons, celebrated surgical educator, dies aged 81
Gregorio A. Sicard, MD, a transformative figure in vascular surgery and a revered mentor to generations of surgeons, has died. He was 81. Sicard was widely recognized for pioneering contributions to the field, particularly in developing and advocating for endovascular…
Enduring PROMISE: Real-world outcomes study suggests results continue to flow from transcatheter arterialization of the deep veins
First retrospective analysis shows comparable outcomes data to those found in PROMISE II pivotal trial, authors report. The first post-approval multicenter analysis of so-called “no-option” chronic limb-threatening ischemia (CLTI) patients treated using a pioneering transcatheter arterialization of the deep veins…
Eastern Vascular Society passes 1,000-member mark
It “takes village” to build a community like the one that the Eastern Vascular Society (EVS) has grown into, outgoing president Brajesh K. Lal, MD, told the EVS annual meeting in Nashville, Tennessee (Sept. 4–7). Lal was delivering the 2025…
Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system
Microbot Medical today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for the Liberty system, the first FDA cleared single use, remotely operated robotic system for peripheral endovascular procedures, states the company in a recent press…
Shape Memory Medical completes enrollment in EMBO-PMS registry
Shape Memory Medical today announced the completion of patient enrollment in the EMBO postmarket surveillance (EMBO-PMS) registry, the company’s prospective, multicenter registry of the Impede and Impede-FX embolisation plugs, and Impede-FX RapidFill device when used for peripheral vascular embolization. A…
EVS 2025: Eastern Vascular Society reveals 2025–26 officer class
Benjamin Jackson, MD, chief in the Division of Vascular and Endovascular Surgery at Lehigh Valley Heart and Vascular Institute in Allentown, Pennsylvania, became the new Eastern Vascular Society (EVS) president during the 2025 EVS annual meeting in Nashville (Sept. 4–7).…